SCHEMBL7367777

SCHEMBL7367777

CC(C)C(=O)Oc1cc(-c2cnc3ccccc3n2)cc([N+](=O)[O-])c1OC(=O)C(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.54
ALDH1A1 P00352 6/20 0.52
SMN1; SMN2 Q16637 6/20 0.52
LMNA P02545 3/20 0.52
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
HTT P42858 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.50
NPC1 O15118 8/20 0.48
RAB9A P51151 7/20 0.48
NPSR1 Q6W5P4 1/20 0.48
KDM4E B2RXH2 2/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
JAK3 P52333 1/20 0.40
ADORA3 P0DMS8 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7369595 0.78 HPGD (0.46) MAPTALDH1A1KMT2AMEN1HTT
SCHEMBL7374010 0.76 MAPT (0.66) MAPTALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL8726194 0.75 PIK3CA (0.43) MAPTALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL8728241 0.74 POLB (0.40) MAPTALDH1A1SMN1; SMN2LMNANPC1
SCHEMBL8733137 0.72 MAPT (0.40) MAPTALDH1A1SMN1; SMN2HTTNPC1
SCHEMBL8731806 0.72 LMNA (0.57) MAPTALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL7366879 0.72 MAPT (0.63) MAPTALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL7367916 0.71 MMP2 (0.40) MAPTALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL7371022 0.71 TDP1 (0.47) MAPTALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL8733117 0.71 NPC1 (0.44) MAPTALDH1A1SMN1; SMN2LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed